HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

Nature Medicine
Jim Dimitroulakos, H Yeger

Abstract

The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, involved in de novo cholesterol synthesis and cell-cycle progression, was identified as a potential mediator of the growth inhibitory effects of retinoic acid on human neuroblastoma. Lovastatin, a nonreversible inhibitor of HMG-CoA reductase, induced extensive cytotoxicity that was restricted to drug-resistant P-glycoprotein-expressing neuroblastoma cell lines. This response was potentiated by dibutyryl cyclic AMP but not retinoic acid. Patients with advanced-stage metastatic neuroblastoma often display an acquired chemoresistant phenotype, which may in part be mediated by P-glycoprotein. Our studies support the application or use of HMG-CoA reductase inhibitors as potential therapeutic agents in the treatment of these patients who are refractory to chemotherapy.

References

Sep 1, 1976·Journal of the National Cancer Institute·L HelsonS K Das
Dec 5, 1991·The New England Journal of Medicine·H S ChanV Ling
Feb 1, 1990·Nature·J L Goldstein, M S Brown
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L J GoldsteinM M Gottesman
Sep 20, 1989·Journal of the National Cancer Institute·J BourhisG Riou
Jan 1, 1985·Survey and Synthesis of Pathology Research·R P Bolande
Dec 1, 1988·Differentiation; Research in Biological Diversity·H YegerM J Phillips
May 1, 1973·The Journal of Clinical Endocrinology and Metabolism·S ImashukuS Miyake
Apr 1, 1995·Nature Medicine·J E Karp, S Broder
Jan 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A CorsiniA L Catapano
Jan 1, 1995·The Journal of Pathology·P Ramani, H Dewchand
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Apr 15, 1994·Cancer·J F KerrB V Harmon

❮ Previous
Next ❯

Citations

Jun 11, 1999·International Journal of Cancer. Journal International Du Cancer·J DimitroulakosH Yeger
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Laura CallerosAntonio Chiloeches
Jul 7, 2001·Journal of the Neurological Sciences·B Cucchiara, S E Kasner
Mar 20, 1999·Transplantation Proceedings·A GórskiL Păczek
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W FeleszkoM Jakóbisiak
Feb 9, 2012·Oncogene·J W Clendening, L Z Penn
Mar 17, 2001·British Journal of Pharmacology·K BogmanJ Drewe
Jan 29, 2000·Journal of Clinical Pharmacy and Therapeutics·A Jardine, H Holdaas
Jan 23, 2003·The Journal of Experimental Medicine·Hans-Jürgen GoberGennaro De Libero
Feb 14, 1998·Journal of the National Cancer Institute·W FeleszkoM Jakobisiak
Aug 28, 1998·The Journal of Pharmacy and Pharmacology·A LindahlH Lennernäs
Jan 23, 2013·The Journal of Clinical Endocrinology and Metabolism·Anna SokalskaAntoni J Duleba
May 16, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Gerd Schmitz, Wolfgang Drobnik
Dec 15, 2007·Current Oncology·H K Takahashi, M Nishibori
Dec 18, 2013·Breast Cancer Research and Treatment·Carolyn A GoardLinda Z Penn
Nov 24, 1999·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·W Wang, R J Macaulay
Sep 13, 2014·Molecular Diversity·Sumit JainAbhay T Sangamwar
Jan 31, 2008·Leukemia & Lymphoma·Lillian P Burke, Cynthia A Kukoly
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Wojciech FeleszkoMarek Jakóbisiak
May 1, 2012·Cancer Letters·Maja Osmak
Jun 26, 2002·Neoplasia : an International Journal for Oncology Research·Jim DimitroulakosSuzanne Kamel-Reid
Jul 5, 2013·International Journal of Cancer. Journal International Du Cancer·Nima NiknejadJim Dimitroulakos
Mar 2, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jennifer J KnoxAmit M Oza
Apr 30, 2005·International Journal of Cardiology·Vincent Launay-VacherGilbert Deray
Apr 3, 2016·Journal of Translational Medicine·Glenwood D GossJim Dimitroulakos
Jan 21, 2015·Nature Reviews. Clinical Oncology·Maya HorowitzShamgar Ben-Eliyahu
Jul 28, 2016·Biophysical Journal·Lorena Redondo-MorataSimon Scheuring
May 4, 2018·Future Oncology·Martyna ZaleskaJacek Bil
Jun 28, 2001·Leukemia & Lymphoma·J DimitroulakosL Z Penn
Nov 23, 2011·Pharmacological Reviews·Patrizia GazzerroMaurizio Bifulco
Mar 22, 2006·The Oncologist·Katja HindlerCharles D Collard
Nov 26, 1998·The Journal of Biological Chemistry·Y LavieM Liscovitch
Aug 19, 2007·The Journal of Biological Chemistry·Nima NiknejadJim Dimitroulakos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.